Incidence and predictors of distal symmetrical polyneuropathy in prediabetes: A 24-month prospective cohort study

Georgia Anastasiou1, Nikolaos Papanas2, Fotios Barkas3

  • 1Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Insights

Prediabetes increases the risk of developing distal symmetrical polyneuropathy (DSPN). Age, male sex, smoking, central obesity, and insulin resistance are key predictors of DSPN in individuals with prediabetes.

Area of Science:

  • Endocrinology
  • Neurology
  • Metabolic Syndrome

Background:

  • Distal symmetrical polyneuropathy (DSPN) is a common diabetes complication, increasingly recognized in earlier dysglycemia stages.
  • Prediabetes is linked to insulin resistance, central adiposity, and dyslipidemia, but DSPN incidence and cardiometabolic associations are understudied.

Purpose of the Study:

  • To prospectively determine the incidence of DSPN in prediabetes patients.
  • To identify predictors of incident DSPN within this population.

Main Methods:

  • 160 prediabetes adults were followed for 24 months.
  • DSPN assessed using neuropathy symptom score (NSS), neuropathy disability score (NDS), and vibration perception threshold (VPT).
  • Multivariable regression analyzed predictors of incident DSPN.

Main Results:

  • 27% of participants had DSPN at baseline; 9.8% developed DSPN over 24 months.
  • Independent predictors included older age, male sex, smoking, larger waist circumference, and higher HOMA-IR (homeostatic model assessment of insulin resistance).
  • Both baseline HOMA-IR and its change over time were significant predictors.

Conclusions:

  • A 9.8% 24-month incidence of DSPN was observed in prediabetes.
  • Age, male sex, smoking, central obesity, and insulin resistance (baseline and change) predict DSPN.
  • Findings suggest potential for screening and prevention strategies in prediabetes.
Abstract

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...